Table 1.
Elevated serum creatinine (Jaffe method) observed following 5-aminolevulinic acid (60 mg/kg)
Subject | Light Dose (J/cm2)3 |
Creatinine 1 | Maximum mucositis grade2 |
|||
---|---|---|---|---|---|---|
Baseline | 1–2 h | 4–5 h | 24 h | |||
1 | 50 continuous |
1.2 | 1.42 | 3 | ||
2 | 50 continuous |
0.87 | 0.82 | 3 | ||
3 | 50 continuous |
0.74 | 1.08 | 0.78 | 2 | |
4 | 50 fractionated |
0.70 | 3.48 | 1.28 | 0.65 | 3 |
5 | 50 fractionated |
0.95 | 0.69 | 3.5 | 1.02 | 3 |
6 | 50 fractionated |
0.63 | 3.8 | Not available |
0.74 | 2 |
7 | 50 fractionated |
0.86 | 4.26 | 1.44 | 0.86 | 2 |
8 | 100 continous |
0.76 | 3.01 | 1.43 | 0.75 | 2 |
9 | 100 fractionated |
0.61 | 3.74 | 1.35 | 0.66 | 3 |
10 | 100 fractionated |
0.80 | 3.19 | 1.66 | 0.74 | 3 |
11 | 100 continous |
0.94 | 0.74 | 1.60 | 0.90 | 2 |
mg/dL (normal range: 0.64–1.27)
NCI Common Toxicity Criteria version 3.0 within the 4 weeks of follow-up evaluation.
Light dose was administered either continuously or interrupted for a time interval of 90–180 seconds.